Cerus Corporation (CERS) Financial Statements (2024 and earlier)

Company Profile

Business Address 1220 CONCORD AVENUE
CONCORD, CA 94520
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments84,50394,680102,154103,827107,047108,557
Cash and cash equivalents20,63527,60435,58528,87532,30938,372
Short-term investments63,86867,07666,56974,95274,73870,185
Receivables22,17525,24234,42628,15126,83725,645
Inventory, net of allowances, customer advances and progress billings40,60836,61429,00328,32927,75828,521
Inventory40,60836,61429,00328,32927,75828,521
Other undisclosed current assets3,6505,6804,5614,4243,03010,089
Total current assets:150,936162,216170,144164,731164,672172,812
Noncurrent Assets
Inventory, Noncurrent      
Operating lease, right-of-use asset12,26812,31312,51212,89013,25913,665
Property, plant and equipment10,25410,83110,96910,64711,20111,659
Intangible assets, net (including goodwill)1,3161,3161,3161,3161,3161,316
Goodwill1,3161,3161,3161,3161,3161,316
Restricted cash and investments1,7931,7851,7731,9982,0142,003
Other noncurrent assets22,29320,87521,37823,82123,99420,451
Total noncurrent assets:47,92447,12047,94850,67251,78449,094
TOTAL ASSETS:198,860209,336218,092215,403216,456221,906
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities54,99955,72358,20563,55247,63048,422
Employee-related liabilities13,678
Accounts payable37,48936,43633,00229,81529,35531,474
Accrued liabilities17,51019,28725,20320,05918,27516,948
Deferred revenue1,3611,6935897549751,258
Debt16,54218,00056,15942,38028,68015,011
Restructuring reserve856     
Other undisclosed current liabilities1,3202,1572,105(11,667)1,9941,968
Total current liabilities:75,07877,573117,05895,01979,27966,659
Noncurrent Liabilities
Long-term debt and lease obligation54,83854,82713,64443,06057,28671,556
Long-term debt, excluding current maturities54,83854,82713,64427,35741,06554,769
Liabilities, other than long-term debt17,25417,37418,8283,2513,1303,280
Other liabilities2,8002,4143,4993,2513,1303,280
Operating lease, liability14,45414,96015,32915,70316,22116,787
Total noncurrent liabilities:72,09272,20132,47246,31160,41674,836
Total liabilities:147,170149,774149,530141,330139,695141,495
Equity
Equity, attributable to parent50,81658,63267,61073,12075,76979,413
Common stock181180177177177177
Additional paid in capital1,089,0831,083,4331,077,3411,069,6291,062,7601,057,497
Accumulated other comprehensive loss(2,433)(2,241)(2,787)(3,189)(2,153)(1,635)
Accumulated deficit(1,036,015)(1,022,740)(1,007,121)(993,497)(985,015)(976,626)
Equity, attributable to noncontrolling interest874930952953992998
Total equity:51,69059,56268,56274,07376,76180,411
TOTAL LIABILITIES AND EQUITY:198,860209,336218,092215,403216,456221,906

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues   188,315   
Operating expenses(41,853)(38,935)(41,774)(36,128)(34,748)(34,792)
Other undisclosed operating income30,21324,78931,82328,68127,91324,944
Operating loss:(11,640)(14,146)(9,951)(7,447)(6,835)(9,848)
Nonoperating expense(1,593)(1,418)(3,407)(1,007)(1,482)(2,360)
Gain (loss), foreign currency transaction, before tax49(193)(622)234(104)(198)
Other nonoperating income (expense)539387(1,088)165(30)(782)
Interest and debt expense(2,181)(1,612)(1,697)(1,406)(1,348)(1,380)
Loss from continuing operations before equity method investments, income taxes:(15,414)(17,176)(15,055)(9,860)(9,665)(13,588)
Other undisclosed income from continuing operations before income taxes2,1811,6121,6971,4061,3481,380
Loss from continuing operations before income taxes:(13,233)(15,564)(13,358)(8,454)(8,317)(12,208)
Income tax expense(98)(77)(267)(67)(78)(76)
Loss from continuing operations:(13,331)(15,641)(13,625)(8,521)(8,395)(12,284)
Loss before gain (loss) on sale of properties:(8,521)(8,395)(12,284)
Net loss:(13,331)(15,641)(13,625)(8,521)(8,395)(12,284)
Net income attributable to noncontrolling interest56221396 
Net loss available to common stockholders, diluted:(13,275)(15,619)(13,624)(8,482)(8,389)(12,284)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(13,331)(15,641)(13,625)(8,521)(8,395)(12,284)
Other comprehensive income (loss)(192)546 (1,036)(518)(1,486)
Other undisclosed comprehensive income   402   
Comprehensive loss:(13,523)(15,095)(13,223)(9,557)(8,913)(13,770)
Comprehensive income, net of tax, attributable to noncontrolling interest56221396 
Comprehensive loss, net of tax, attributable to parent:(13,467)(15,073)(13,222)(9,518)(8,907)(13,770)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: